Literature DB >> 22492695

Predicting and accounting for VTE in phase I cancer studies.

A A Khorana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22492695      PMCID： PMC3360549          DOI： 10.1093/annonc/mds073

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  13 in total

1.  Malignancy, thrombosis and Trousseau: the case for an eponym.

Authors:  A A Khorana
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

2.  Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'.

Authors:  M Mandala; M Clerici; I Corradino; C Vitalini; S Colombini; V Torri; A De Pascale; S Marsoni
Journal:  Ann Oncol       Date:  2011-11-02       Impact factor: 32.976

3.  Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance.

Authors:  Casey L O'Connell; William D Boswell; Vinay Duddalwar; Amy Caton; Lisa S Mark; Cheryl Vigen; Howard A Liebman
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

4.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

5.  The incidence of venous thromboembolism among patients with primary lung cancer.

Authors:  H K Chew; A M Davies; T Wun; D Harvey; H Zhou; R H White
Journal:  J Thromb Haemost       Date:  2008-01-17       Impact factor: 5.824

6.  Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.

Authors:  Grace H Ku; Richard H White; Helen K Chew; Danielle J Harvey; Hong Zhou; Ted Wun
Journal:  Blood       Date:  2008-12-16       Impact factor: 22.113

7.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

8.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

Authors:  Alok A Khorana; Charles W Francis; Eva Culakova; Nicole M Kuderer; Gary H Lyman
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

9.  Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.

Authors:  Sushma Vemulapalli; Lakshmi Chintala; Apostolia-Maria Tsimberidou; Navjot Dhillon; Xiudong Lei; David Hong; Razelle Kurzrock
Journal:  Am J Hematol       Date:  2009-07       Impact factor: 10.047

Review 10.  Assessing risk of venous thromboembolism in the patient with cancer.

Authors:  Alok A Khorana; Gregory C Connolly
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.